Depressive Symptoms: Clinical Trials

4 trials for Depressive Symptoms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Depressive Symptoms: new trials by email Literature Review of Depressive Symptoms trials Research Report on Depressive Symptoms

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
VTS-K - Treatment Resistant Depression, Major Depressive Disorder
Phase 4CompletedTheresa Jacob, PhD, MPH152022-12-062026-04-21
Dexamethasone and Ketamine on Change of Postoperative Mood
Ketamine Hydrochloride, dexamethasone, and combination of two drugs - Depressive Symptoms
Phase 4CompletedWonkwang University Hospital932017-05-022017-06-21
Rasagiline in Cognitive-impairment Related Depression: AzileCt in COgnitive-impairment Related DepressiOn
Rasagiline, Placebo - Depressive Symptoms, Parkinson's Disease
Phase 4CompletedLundbeck Italia S.p.A.1212010-03-012021-08-31
Combination Therapy in Patients With Depression
Atomoxetine Hydrochloride, Sertraline, Placebo - Depressive Symptoms
Phase 4CompletedEli Lilly and Company2142003-06-012007-06-13

Narrower conditions

Depression (4)  ·  Agnosia (1)  ·  Depressive Disorder, Major (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Parkinson Disease (1)

Broader conditions

Behavior (4)  ·  Behavioral Symptoms (4)  ·  Nervous System Diseases (2)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Depressive Disorder (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Movement Disorders (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)  ·  Parkinsonian Disorders (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Ketamine (2)  ·  Aspirin (1)  ·  Atomoxetine Hydrochloride (1)  ·  Dexamethasone (1)  ·  Sertraline (1)  ·  rasagiline (1)

Sponsors

Eli Lilly and Company (1)  ·  Lundbeck Italia S.p.A. (1)  ·  Theresa Jacob, PhD, MPH (1)  ·  Wonkwang University Hospital (1)

Countries

United States (2)  ·  Italy (1)  ·  South Korea (1)

Top investigators

Cheol Lee, M.D.,Ph.D (1)  ·  Theresa Jacob, PhD, MPH (1)

Results publications

PMID 19969374

NIH funding

2009 (1)